Transforming Microbial Testing
Survaid - Introduces transformational solutions that transform microbial testing environments through the power of AI and cobotics. SURVAID optimizes clinical trials for diseases such as chlamydia, COVID19, HIV, malaria and tuberculosis. Its intelligent AI algorithm simplifies testing by dividing patients into groups based on the probability of infection and optimizing pool size based on patient conditions and various other factors Using machine learning, hospitals and clinics are able to constantly improve the model to suit their populations.




Watch what Survaid is capable of
See Survaid in action

Merging AI-driven efficiency with a patient centric approach.
We emphasize innovatoin and sustainability.
Easy-to-use mobile application
Users can easily perform anonymous health checks using our user-friendly mobile application. In exchange, users receive a unique ID that provides complete privacy and ease of use.
Interpretable Scientific AI
Our system today divides people into groups according to their risk of infection. This discreet grouping not only enables this efficient group testing, but also efficiently allocates resources for optimal results.
Online Collaboration
The Survaid platform provides a smooth yield management system and an automated retesting mechanism. Administrators’ workflow is streamlined because the entire process is securely tracked through a powerful online dashboard.
Multidisease Application
Survaid means more than a narrow focus. It is geared to handle research on various diseases such as chlamydia, COVID-19, HIV, malaria and tuberculosis to ensure widespread use
What we are trying to do
With Survaid, we're charting a visionary course to transform healthcare testing. Dive deeper into our goals:
Testimonials
See what our testimonials say
FAQ
Your Top Questions Answered here
Survaid is a dynamic solution developed by Segtnan to optimize virus testing facility processes using cobots and artificial intelligence. It is designed for healthcare institutions like hospitals, labs, and departments of microbiology and biochemistry.
Group testing faces difficulties like fluctuating prevalence, high costs in high prevalence areas, and dilutional effects threatening test accuracy. SURVAID uses an 'individualized AI' to standardize and automate lab protocols for each patient and lab, effectively addressing these challenges.
Survaid uses a scientifically proven AI algorithm that outcompetes traditional equations, like Robert Dorfman's 1943 equation. Our trials with more than 3500 patients showed an accuracy of 80-85%, delivering significant savings even in highly prevalent areas.
Survaid can effectively test for Chlamydia, COVID19, HIV, Malaria, and Tuberculosis.
Users fill in an anonymous health survey on the mobile app, generating a unique identifier. This identifier is used throughout the process to respect users' privacy.
The AI determines whether to pool a patient's sample based on their clinical condition, and the pool size is determined individually. The AI also considers geographic location, lab procedures, and molecular diagnostics in its calculations.
Our AI software is CE-marked and evaluated to be compliant with GDPR. It is incrementally trained and can be shared among labs without carrying sensitive patient data.
With Survaid, you can expect a significant reduction of up to 70% in overall costs, depending on the disease prevalence.
Survaid works seamlessly with existing lab equipment like the UR arm and the T&O ATRAS sorter to automate and optimize medical test sorting into appropriate pool sizes.
Yes, by using Survaid, you can reduce CO2 emissions by 1.8 kg per 100 medical PCR tests, contributing to a greener and healthier planet.
Join the fight against diseases like Chlamydia, HIV, and COVID19 with SURVAID.
Contact us to save money and boost testing accuracy. Let's tackle pandemics better together.